Additionally, the overexpression of eIF4A1 has been positively associated with advanced tumor-node-metastasis (TNM) stage, poor tumor differentiation, and a poor prognosis in patients with GC (Gao et al., 2020). The gene discussed is EIF4A1; the disease is neoplasm.